EX-23.1 4 exhibit231toforms-8xmay2023.htm EX-23.1 Document

Exhibit 23.1
 
Consent of Independent Registered Public Accounting Firm
 
We consent to the incorporation by reference in this Registration Statement on Form S-8 of Cumberland Pharmaceuticals Inc. (Company) of our report dated March 13, 2023, on our audits of the consolidated financial statements of the Company as of December 31, 2022 and 2021, and for each of the two years in the period ended December 31, 2022, which report is included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.
/s/ FORVIS, LLP
Nashville, Tennessee
May 16, 2023